Pivotal held its long-delayed shareholders' meeting Monday, giving its investors a chance to ratify at last the company's
plans to sell itself. Pivotal is scheduled to close Wednesday on its acquisition by Chinadotcom unit CDC Software, according
to a Pivotal spokesman. The company expects to know the results of the shareholders' vote on Tuesday and expects them to approve
the deal.
The midmarket CRM (customer relationship management) software maker became the target of an unexpected bidding war late last
year. After soliciting bidders to take over the financially struggling firm, Pivotal's management accepted a cash offer from
an investment firm that planned to merge the company with another CRM vendor, Talisma. Shortly before the intended shareholders'
vote on that deal, a rival company, Onyx Software, stepped in with an unsolicited stock-based acquisition offer. While Pivotal's
management put together its rejection of Onyx's offer, CDC Software stepped in with its own unsolicited bid -- a cash-and-stock
mix Pivotal's board ultimately deemed superior to its agreement with Talisma. When the dust settled, CDC Software was the
suitor left standing.
Pivotal and CDC Software said they will elaborate later this week on their acquisition plans and product roadmap. Executives
have said previously that Pivotal will continue operating as a separate business unit and remain in its Vancouver headquarters,
while CDC Software uses Pivotal's CRM technology as a component in the ERP (enterprise resource planning) software it is building.
CDC Software said it will target that suite toward customers in Asia-Pacific, the territory on which it focuses.
E-mail
Printer Friendly
Reprints
(InfoWorld) - In the litigious world we live in, deploying a unified communications platform in your enterprise could...
